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1. Introduction 
The major component of membranous lipids is rep- 
resented by phospholipids [l] . It is well known that 
this class of lipids plays an important role in regulating 
the biochemical properties of subcellular particles [2] . 
Moreover, there exists a cholesterol:phospholipid ratio 
peculiar for several kinds of membranes [3]. Choles- 
terol is important in stabilizing arrays of phospholipids 
in cellular and cytoplasmic membranes [4,5] , and in 
regulating the permeability to small molecules of arti- 
ficial [6,7] and natural [8] membranes. Lipid-lipid 
interactions play an important role in the interaction 
between lipid and protein [3] ; the protein conforma- 
tion is greatly influenced by their association with the 
lipid environment [9]. Alterations in the protein com- 
ponents of mitochondrial membranes have been ob- 
served in hepatoma mitochondria [ 10,l l] . They 
could be, at least in part, explained by changes in the 
lipid composition of membranes. In hepatoma mito- 
chondria, we have also found functional changes, 
which could be related to high fragility and to an in- 
creased resistance to deformation and stretching 
[ 12,131 . Similar alterations have been observed also 
in cholesterol-enriched mitochondria [5] . 
The knowledge of lipid composition of membranes 
isolated from tumors is lacking and, sometimes, con- 
trasting [ 14,151 . As a first approach to this problem 
we have studied the phospholipid and cholesterol con- 
tent of mitochondria and microsomes isolated from 
rat liver and Morris hepatoma 5 123. 
2. Methods 
Female Buffalo rats (150-l 80 g) were used to 
transplant Morris hepatoma 5123, and as a source of 
normal liver. Mitochondria were isolated as described 
previously [ 131 and washed three times. Some mito- 
chondrial preparations were further purified as sug- 
gested by Neubert et al. [ 161 . In order to isolate mi- 
crosomes the post-mitochondrial supernatants were 
first centrifuged at 250,000 g-min and washed once. 
Microsomes were sedimented from the collected super- 
natants, at 6 X lo6 g-min. Soluble and insoluble frac- 
tions of sonicated mitochondria were separated as de- 
scribed by Mitchell [i 71 . Glucose-6-phosphate dehy- 
drogenase was determined according to Lohr and 
Waller [ 181, cytochrome c oxidase according to 
De Duve et al. [ 191, malate dehydrogenase according 
to Schnaitman and Greenawalt [20] , glucose-6-phos- 
phatase according to Swanson [21] . Total lipids were 
isolated according to Folch et al. [22]. Neutral and 
polar lipids were separated by silicic acid columns 
(Unisil, Clarkson, Pa., USA); the different classes of 
phospholipids were separated and determined accord- 
ing to Skipski et al. [ 231. Cholesterol was isolated by 
thin-layer chromatography using as a solvent n-hep- 
tane:isopropylether:formic acid (60:40:2), and deter- 
mined according to Bowman and Wolf [24]. A biuret 
method was used to determine the protein [25]. 
3. Results 
The data in table 1 show that the glucose-6-phos- 
phatase activity is about 13- 14 times higher in 
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Table 1 
Glucose-6-phosphatas and cytochrome c oxidase activities in 
mitochondrial nd microsomal fractions from liver and hepa- 
toma. 
Fraction Glucose-6- 
phosphatase 
(nmoles of 
Pi/min/mg) 
Cytochrome c 
oxidase 
(nmoles of cyt. c 
oxidized/min/mg) 
Liver 
Mitochondria 
Microsomes 
Hepatoma 
16.4 * 4.8 1,100 * 158 
234 f 16 10.0+ 5.8 
Mitochondria 
Microsomes 
5.2 f 1.5 1,097 f 90 
61 f 4 8.4 f 4.1 
Mean values of 3 expts. c S.D. 
microsomal than in mitochondrial fractions from both 
liver and hepatoma, indicating that the extent of mi- 
crosomal contamination is about 7%. The cytochrome 
c oxidase is 1 lo- 130 times higher in mitochondria 
than in microsomes from both tissues; this corre- 
sponds to a concentration of mitochondria in the mi- 
crosomal fraction lower than 1%. The contamination 
of mitochondria by red cells, whose high content of 
cholesterol is known [3] , was considered. The activi- 
ty of glucose-6-phosphate dehydrogenase, a marker 
for erythrocytes, was almost absent in mitochondria. 
As shown in table 2, the cholesterol and phospholipid 
contents in normal liver mitochondria are, respective- 
ly, about 50% and 70% lower than in microsomes. In 
hepatoma, the cholesterol content is higher in mito- 
chondria than in microsomes. This arises from a sig- 
nificant increase in cholesterol per mg of mitochon- 
drial protein, the cholesterol content per mg of pro- 
tein being unchanged in microsomes. The phospholip- 
id content is greatly decreased in both mitochondria 
and microsomes from hepatoma, as compared with 
the same particles from liver. If we consider the molar 
ratio cholesterol:phospholipid, we observe a S-times 
increase in hepatoma mitochondria and a 2.7-times in- 
crease in hepatoma microsomes. In some experiments 
the mitochondria from both liver and hepatoma have 
been submitted to a further purification according to 
Neubert et al. [ 161. Differences have not been found 
between the not-purified and the purified prepara- 
tions in the content of both cholesterol and phospho- 
lipids. As this purification removes essentially nuclei 
and nuclear fragments [ 161 , our data indicate that 
the latter contaminants do not contribute to the ob- 
served differences between the particles from liver 
and hepatoma. 
Parsons and Yano [26] have reported that mito- 
chondrial cholesterol is essentially located in the 
membrane fraction, mainly in the outer membrane. 
In order to determine to what extent the membranes 
contribute to the cholesterol increase in hepatoma 
mitochondria, we have separated the soluble from 
the insoluble compartment of mitochondria as de- 
scribed by Mitchell [ 171 . As shown in table 3 the 
strong sonication releases 40% of protein in liver 
Table 2 
Cholesterol and phospholipid content of mitochondria nd microsomes from liver and hepatoma. 
Fraction Cholesterol 
Wmg Protein) 
Phospholipid 
(mg/mg protein) 
Cholesterol 
(Mg/mg phospholipid) 
Molar ratio* 
(Cholesterol:phospholipid) 
Liver 
Mitochondria 
Microsomes 
Hepatoma 
Mitochondria 
Microsomes 
12.3 + 3.3 (8) 0.187 + 0.015 6.5 * 10.8 1:8.5 
25.9 + 5.1 0.283 f 0.079 91 f 30.3 1:6.0 
40.8 f 8.2 (6) 0.115 * 0.035 (6) 355 * 129.0 1:1.6 
25.8 f 3.2 (4) 0.102 + 0.010 (4) 258 f 40.8 1:2.2 
* Mol. wt. of cholesterol = 387, phospholipid = 700. 
Mean values * S.D. Number of experiments in parentheses. The S.D. of the ratio cholesterol:phospholipid (pg/mg) was calculated 
according to Worthing and Jeffner [ 331. 
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Table 3 
Cholesterol content of insoluble fraction of liver and hepatoma mitochondria. 
Source of Protein 
mitochondria Soluble Insoluble 
Malate dehydrogenase 
Soluble Insoluble 
Cholesterol 
Insoluble 
Liver 
Hepatoma 
4oi 2 60+ 4 805 15 16+ 6 82 f 10 
29* 2 71+ 2 75 f 12 21 f 3 765 4 
Mitochondria (30 mg of protein) were suspended in 20 ml of water and submitted to 3 min of sonication at 0” using a Biosonik 
III sonifier at its maximum output; 9 ml aliquots were then centrifuged at 21 X lo6 g-mm The supernatant and sediment are re- 
ferred to as soluble and insoluble components, respectively. The data (mean values of 4 expts. + S.D.) are expressed as percent of 
the total content measured in sonicated, unfractionated mitochondria. 
mitochondria and 29% in hepatoma mitochondria, and 
respectively, 80% and 75% of the matrix enzyme mal- 
ate dehydrogenase in both liver and hepatoma mito- 
chondria. The main fraction of cholesterol is clearly 
bound to the insoluble material in both types of mito- 
chondria. 
As far as the phospholipid composition of mito- 
chondria and microsomes is concerned, data in fig. 1 
show that no appreciable differences occur between 
hepatoma and liver subcellular particles. In both tis- 
sues we have found the same difference in the distribu- 
tion of the phospholipid classes between microsomes 
and mitochondria. In fact, cardiolipin is high in mito- 
chondria and almost absent in microsomes; on the 
other hand, sphingomyelin is higher in microsomes 
than in mitochondria. 
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Fig. 1. Phospholipid classes in mitochondria and microsomes 
from liver and hepatoma. The data (mean values of 5 expts. 
f S.D.) are given as percent of the total phospholipids. 
4. Discussion 
Our data indicate that a significant increase of cho- 
lesterol occurs in mitochondria from Morris hepatoma 
5123. It is unlikely that such results depend on the 
impurity of the subcellular fractions. This is shown by 
the distribution of the activities of the marker en- 
zymes in our fractions. Moreover, a supporting datum 
of an acceptable separation between mitochondria 
and microsomes in liver and hepatoma 1s given by the 
distribution of cardiolipin and sphingomyelin, which 
specifically characterizes the two subcellular particles. 
Moreover, the molar ratio cholesterol:phospholipids 
in our liver organelles is in agreement with that calcu- 
lated on the basis of the cholesterol content observed 
by others [5,27,28]. 
It has been shown [S, 291 that the in uivo choles- 
terol enrichment of liver mitochondria renders them 
more resistant to the large amplitude swelling and to 
the changes occurring in the conformation of the par- 
ticles associated with changes of the metabolic state. 
This probably arises from an increased strength of the 
membranes and/or from a reduced ability to exchange 
ions [S, 81. A very high resistance to large amplitude 
swelling and to conformational changes was also 
found in hepatoma mitochondria [ 12,301, so that we 
might suggest he hypothesis that these alterations 
could be related to the high cholesterol content in 
hepatoma mitochondria. In this case our data could 
give some insight to the problem of the existence of 
alterations of the mitochondrial dynamics in the in- 
tact tumor cell, as it is probable that the increase in 
mitochondrial cholesterol is present in the unfraction- 
ated hepatoma cells. An increase in cholesterol per 
phospholipid molecule has also been found in micro- 
somes; van Hoeven and Emmelot [3] have observed 
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an increase of cholesterol content in hepatoma plas- 
ma membrane. The high cholesterol levels in different 
subcellular particles from hepatomas could reflect the 
loss of feedback inhibition of cholesterol biosynihesis 
in these tumors [32]. 
The lack of any differences between hepatoma and 
liver in the phospholipid composition in mitochondria 
and microsomes contrasts with the results of 
Bergelson et al. [ 151 , who found that the phospholip- 
id classes of the different membranes are almost 
equalized in tumor cells and suggested the existence 
of a chemical dedifferentiation of tumor cellular mem- 
branes. 
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